Articles related to PATIENT SAFETY

In light of the voluntary recall of Neptune’s Fix due to its dangerous ingredient, tianeptine, healthcare professionals should be vigilant in advising patients against the use of unregulated supplements and emphasize the importance of FDA-approved treatments.

This study underscores the critical gap between Hollywood’s depiction of cancer care and the realities of diagnosis, treatment, and palliative care, urging healthcare professionals to actively correct patient misconceptions for more realistic expectations.

With an increase in lawsuits for failure to diagnose or delayed diagnosis, it’s clear that enhancing diagnostic processes and patient communication is essential for reducing legal risks and improving outcomes.

This study uncovers a critical connection between contaminated pituitary-derived hormone treatments and the subsequent development of early-onset Alzheimer’s disease, highlighting the necessity for stringent safety protocols in medical treatments.

Physicians should be acutely aware of the heightened risk of neuroinvasive arboviral infections in patients treated with rituximab, necessitating a shift towards molecular diagnostic testing for timely and accurate detection.

Recent evidence suggests that the initiation of treatment with thiazide diuretics carries a more substantial risk for hyponatremia than previously recognized, particularly in the initial months of treatment.